Quote | Solo Brands Inc. Class A (NYSE:DTC)
Last: | $2.01 |
---|---|
Change Percent: | -0.5% |
Open: | $2.01 |
Close: | $2.01 |
High: | $2.1 |
Low: | $2 |
Volume: | 230,698 |
Last Trade Date Time: | 05/14/2024 03:00:00 am |
News | Solo Brands Inc. Class A (NYSE:DTC)
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce the...
2024-05-13 07:59:56 ET Summary JAKKS Pacific's Q1 2024 results show mixed performance, with revenue of $90.1M (12% higher than expected) but adjusted EPS of -$1.09 (28% worse than expected). The company had previously anticipated weak results for the first half of 2024 due to a la...
Message Board Posts | Solo Brands Inc. Class A (NYSE:DTC)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Solo Brands Inc. Class A Company Name:
DTC Stock Symbol:
NYSE Market:
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce the...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...